Diagnosis, risk factors, and treatment of vascular dementia

Current Neurology and Neuroscience Reports

Volumn 4, Issue 5, 2004, Pages 358-367

  Lopez, Oscar L ^a   Kuller, Lewis H ^a   Becker, James T ^a  

^a Department of Neurology ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GINKGO BILOBA EXTRACT; MEMANTINE; NAFTIDROFURYL; NIMODIPINE; OXIRACETAM; PENTOXIFYLLINE; PIRACETAM; POSATIRELIN; PROPENTOFYLLINE; SULODEXIDE; XANTHINE DERIVATIVE;

ALZHEIMER DISEASE; ANAMNESIS; ARTICLE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEMENTIA; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROPATHOLOGY; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; STROKE; SYMPTOMATOLOGY; VASCULAR DISEASE;

EID: 5444222589     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-004-0082-9     Document Type: Article

References (89)

1. Ball B, Chambard E, Demence R: In Dicctionnaire Encyclopedique des Sciences Medicales. Edited by Dechambre A, Lerboullet L. Paris: Mason; 1881: 559-605.
2. Alzheimer A: Mental disturbances of arteriosclerotic origin. Neuropsychiatr Neuropsychol Behav Neurol 1992, 5: 1-6.
3. Alvarez WC: Small infarcts of the brain. Geriatrics 1946, 1: 189-216.
4. Hachinski VC, Lassen NA: Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 1974, 2: 207-210.
5. Chui HC, Mack W, Jackson JE, et al.: Clinical criteria for the diagnosis of vascular dementia. Arch Neurol 2000, 57: 191-196.
6. Roman GC, Tatemichi TK, Erkinjuntti T, et al.: Vascular dementia: diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop. Neurology 1993, 43: 250-260.
7. Erkinjunnti T, Inzitari D, Pantoni L, et al.: Research criteria for subcortical vascular dementia in clinical trials. J Neural Tranms 2000, 59(Suppl): 23-30.
8. Esiri MM, Wilcock GK, Morris JH: Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997, 63: 749-753.
9. Hulette C, Nochlin D, McKeel DW, et al.: Clinical-neuropathologic findings in multi-infarct dementia: A report of six autopsied cases. Neurology 1997, 48: 668-672.
10. Zekry D, Duyckaerts C, Belmin J, et al.: The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy. Neurobiol Aging 2003, 24: 213-219.
11. Tomlinson BE, Blessed G, Roth M: Observations on the brain of demented old people. J Neurol Sci 1970, 11: 205-242.
12. Galasko D, Hansen LA, Katzman R, et al.: Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 1994, 51: 888-895.
13. Snowdon DA, Grainer LH, Mortimer JA, et al.: Brain infarction and the clinical expression of Alzheimer disease: The nun study. JAMA 1997, 277: 813-817.
14. Schneider JA, Wilson RS, Cochran EJ, et al.: Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 2003, 60: 1082-1088.
15. De Reuck J, Crevits L, De Coster W, et al.: Pathogenesis of Binswanger chronic progressive subcortical encephalopathy. Neurology 1980, 30: 920-928.
16. Roman GC: From UBOs to Binswanger's disease: impact of magnetic resonance imaging on vascular dementia research. Stroke 1996, 27: 1269-1273.
17. Chapman LF, Wolff HG: The cerebral hemispheres and the highest integrative functions of man. Arch Neurol 1959, 1: 357-424.
18. Selden NR, Gitelman DR, Salamon-Murayama N, et al.: Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 1998, 121: 2249-2257.
19. Mielke R, Herholz K, Grond M, et al.: Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch Neurol 1992, 49: 909-913.
20. White L, Petrovich H, Hardman J, et al.: Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann NY Acad Sci 2002, 977: 9-23.
21. Kril JJ, Patel S, Harding AJ, et al.: Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J Neurol Neurosurg Psychiat, 2002, 72: 747-751.
22. Damasio AR, Eslinger PJ , Damasio H, et al.: Multimodal amnesic syndrome following bilateral temporal and basal forebrain damage. Arch Neurol 1985, 42: 252-259.
23. Kertesz A, Clysdesdale S: Neuropsychological deficits in vascular dementia vs Alzheimer's disease: frontal lobe deficits prominent in vascular dementia. Arch Neurol, 1994, 51: 1226-1231.
24. Rinne JO, Portin R, Ruottinen H, et al.: Cognitive impairment and the brain dopaminergic system in Parkinson disease. Arch Neurol 2000, 57: 470-475.
25. Min WK, Park KK, Kim YS: Atherothrombotic middle cerebral artery territory infarction: topography diversity with common occurrence of concomitant small cortical and subcortical infarcts. Stroke 2000, 31: 2055-2061.
26. Graham NL, Emery T, Hodges J: Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry, 2004, 75: 61-71.
27. Bogousslavsky J, Bernasconi A, Kumral E: Acute multiple infarction involving the anterior circulation. Arch Neurol, 1996, 53: 50-57.
28. Groves WC, Brandt J, Steinberg M, et al.: Vascular dementia and Alzheimer's disease: Is there a difference? A comparison of symptoms by disease duration. J Neuropsychiatry Clin Neurosci 2000, 12: 305-315.
29. Boiten J, Lodder J: Large striatocapsular infarcts: clinical presenttaion and pathogenesis in comparison with lacunar and cortical infarcts. Acta Neurol Scand 1992, 86: 298-303.
30. Marshall JC: The description and interpretation of aphasic language disorder. Neuropsychologia 1986, 24: 5-24.
31. Knopman DS, Parisi JE, Boeve BF, et al.: Vascular dementia in a population-based autopsy study. Arch Neurol 2003, 60: 569-575.
32. Graff-Radford NR, Eslinger PJ, Damasio AR, et al.: Nonhemorrhagic infarction of the thalamus: Behavioral, anatomic, and physiologic correlates. Neurology 1984, 34: 14-23.
33. Kumral E, Evyapan D, Balkir K: Acute caudate vascular lesions. Stroke 1999, 30: 100-108.
34. Tatemichi TK, Steinke W, Duncan C, et al.: Paramedian thalamopeduncular infarction: clinical syndromes and magnetic resonance imaging. Ann Neurol, 1992, 32: 162-171.
35. Benson DF, Cummings JL, Tsai SY: Angular gyrus syndrome simulating Alzheimer's disease. Arch Neurol 1982, 39: 616-620.
36. Ott BR, Saver JL: Unilateral amnesic stroke. Six new cases and a review of the literature. Stroke 1993, 24: 1033-1042.
37. American Psychiatric Association: DSM-IV: Diagnostic and Statistic Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.
38. World Health Organization: The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization; 1993.
39. Chui HC, Victoroff JI, Margolin D, et al.: Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992, 42: 473-480.
40. Erkinjuntti T, Inzitari D, Oantoni L, et al.: Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl, 2000, 59: 23-30.
41. Moroney JT, Bagiella E, Hachinski VC, et al.: Misclassification of dementia subtype using the Hachinski Ischemic Score: Results of a meta-analysis of patients with pathologically verified dementias. Ann NY Acad Sci 1997, 826: 490-492.
42. Lopez OL, Larumbe MR, Becker JT, et al.: Reliability of NINDS-AIREN criteria for vascular dementia. Neurology 1994, 44: 1240-1245.
43. Verhey FR, Lodder J, Rozendaal N, et al.: Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology 1996, 15: 166-172.
44. Pohjasvaara T, Erkinjuntti T, Vataja R, et al.: Dementia three months after stroke: Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke 1997, 28: 785-792.
45. Wetterling T, Kanitz RD, Borgis KJ: Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996, 27: 30-36.
46. Meguro K, Ishii H, Yamaguchi S, et al.: Prevalence of dementia and dementing diseases in Japan. Arch Neurol 2002, 59: 1109-1114.
47. Gold G, Bouras C, Canuto A, et al.: Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry 2002, 159: 82-87.
48. Hogervorst E, Bandelow S, Combrinck M, et al.: The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach. Dement Geriatr Cogn Disord 2003, 16: 170-180.
49. Holmes C, Cairns N, Lantos P, et al.: Validity of current clinical criteria for Alzheimer's disease, vascular dementia, and dementia with Lewy bodies. Br J Psychiatry 1999, 174: 45-50.
50. Lopez OL, Kuller LH, Fitzpatrick A, et al.: Evaluations of dementia in the cardiovascular health cognition study. Neuroepidemiology 2003, 22: 1-12.
51. Tatemichi TK, Desmond DW, Mayeux R, et al.: Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992, 42: 1185-1193.
52. Altieri M, DiPiero V, Pasquini M, et al.: Delayed poststroke dementia. A 4-year follow-up study. Neurology 2004, 62: 2193-2197.
53. Knopman DS, Rocca WA, Cha RH, et al.: Incidence of vascular dementia in Rochester, Minn, 1985-1989. Arch Neurol 2002, 59: 1605-1610.
54. Liu CK, Miller BL, Cummings JL, et al.: A quantitative MRI study of vascular dementia. Neurology 1992, 42: 138-143.
55. del Ser T, Bermejo F, Portera A, et al.: Vascular dementia. A clinicopathological study. J Neurol Sci 1990, 96: 1-17.
56. van Straaten EC, Scheltens P, Knol DL, et al.: Operational definitions for the NINDS-AIREN criteria for vascular dementia. Stroke 2003, 34: 1907-1916.
57. Henon H, Durieu I, Guerouaou D, et al.: Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 2001, 57: 1216-1222.
58. Kuller LH, Shemanski L, Manolio T, et al.: Relationship between ApoE, MRI findings, and cognitive function in the cardiovascular health study. Stroke 1998, 29: 388-398.
59. Ikeda M, Hokoishi K, Maki N, et al.: Increased prevalence of vascular dementia in Japan. Neurology 2001, 57: 839-844.
60. Yoshitake T, Kiyohara Y, Kato I: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese opoulation: the Hisyama study. Neurology 1995, 45: 1161-1168.
61. Yamada T, Hattori H, Miura A, et al.: Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population. Psychiatry Clin Neurosci 2001, 55: 21-25.
62. Chui H, Mack W, Jackson JE, et al.: Clinical criteria for the diagnosis of vascular dementia: A multicenter study of comparability and interrater reliability. Arch Neurol 2000, 57: 191-196.
63. Pohjasvaara T, Mantyla R, Salonen O, et al.: How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol 2000, 57: 1295-1200.
64. Desmond DW, Moroney JT, Paik MC, et al.: Frequency and clinical determinants of dementia after ischemic stroke. Neurology 2000, 54: 1124-1131.
65. Kuller LH, Lopez OL, Newman A, et al.: Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 2003, 22: 13-22.
66. Slooter AJ, Tang M, van Dujin CM, et al.: Apolipoprotein E epsilon4 and the risk of dementia with stroke: a population based investigation. JAMA 1997, 277: 818-821.
67. Myers RH, Schaefer EJ, Wilson PW, et al.: Apolipoprotein E e4 association with dementia in a population-based study: The Framingham Study. Neurology 1996, 46: 673-677.
68. Stengard JH Pekkanen J, Sulkava R, et al.: Apolipoprotein E polymorphism, Alzheimer's disease and vascular dementia among elderly Finnish men. Acta Neurol Scand 1995, 92: 297-298.
69. Barba R, Martinez-Espinosa S, Rodriguez-Garcia E, et al. Poststroke dementia. Clinical features and risk factors. Stroke 2000, 31: 1494-1501.
70. Moroney JT, Bagiella E, Tatemichi TK, et al.: Dementia after stroke increases the risk of long-term stroke recurrence. Neurology 1997, 48: 1317-1325.
71. Aguerro-Torres H, Fratiglioni L, Guo A, et al.: Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc 1998, 46: 444-452.
72. Cosway R, Strachan MW, Dougall A, et al.: Cognitive function and informationa processing in Type 2 diabetes. Diabetes Med 2001, 18: 803-810.
73. Launer LJ, Masaki K, Petrovitch H, et al.: The association between mid-life blood pressure levels and late life cognitive function: The Honolulu-Asia Aging Study. JAMA 1995, 274: 1846-1851.
74. Skoog I, Lernfeldt B, Landahl S: 15-year longitudinal study of blood pressure and dementia. Lancet 1996, 347: 1141-1145.
75. Forette F, Seux ML, Staessen JA, et al.: Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet 1998, 352: 1347-1351.
76. Parnetti L, Mari D, Abate G, et al.: Vascular Dementia Italian Sulodexide Study (VADISS). Clinical and biological results. Thromb Res 1997, 87: 225-233.
77. Meyer JS, Rother M, Kittner B, et al.: Daily aspirin for multi-infarct dementia. J Am Geriatr Soc 1996, 37: 549-555.
78. Rother M, Erkinjuntti T, Roessner M, et al.: Propentofylline in the treatment of Alzheimer's disease and vascular dementia: a review of phase III trials. Dement Geriatr Cogn Disord 1998, 9(Suppl 1): 36-43.
79. The EPMID Study Group: European Pentoxifylline Multi-infarct Dementia Study (EPMID). Eur Neurol 1996, 36: 315-321.
80. Pantoni L, Bianchi C, Beneke M, et al.: The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia. J Neurol Sci 2000, 175: 116-123.
81. Winblad B, Poritis N: Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry 1999, 14: 135-146.
82. LeBars PL, Katz MM, Berman N, et al.: A placebo-controlled, double-blind, randomized trial of an extract of Gingko biloba for dementia. North American EGb Study Group. JAMA 1997, 278: 1327-1332.
83. van Dongen MC, van Rossum E, Kessels AG, et al.: The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc 2000, 48: 1183-1194.
84. Emeriati JP, Lehert P, Mosnier M: Efficacy of naftidrofuryl in patients with vascular or mixed dementia: results of a multicenter, double-blind trial. Clin Ther 2000, 22: 834-844.
85. Maina G, Fiori L, Torta R, et al.: Oxiracetam in the treatment of primary degenerative and multi-infarct dementia: a double-blind, placebo-controlled study. Neuropsychobiology 1989, 21: 141-145.
86. Black S, Roman GC, Geldmacher DS, et al.: Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multi-center, international, randomized, placebo-controlled clinical trial. Stroke 2003, 34: 2323-2330.
87. Erkinjuntti T, Kurz A, Gauthier S, et al.: Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002, 359: 1283-1290.
88. Censori B, Manara O, Agostinis C, et al.: Dementia after first stroke. Stroke 1996, 27: 1205-1210.
89. Inzitari D, DiCarlo A, Pracucci G, et al.: Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based stroke registry. Stroke 1998, 29: 2087-2093.